Daiki Miki Selected Research

hepatitis B surface antigen presurface protein 1

1/2021

Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daiki Miki Research Topics

Disease

41	Infections 02/2022 - 06/2009
26	Chronic Hepatitis C 01/2021 - 09/2010
25	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2007
15	Chronic Hepatitis B 01/2022 - 08/2010
14	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 09/2010
11	Fibrosis (Cirrhosis) 07/2022 - 01/2008
11	Neoplasms (Cancer) 05/2022 - 10/2007
6	Hepatitis B 01/2022 - 03/2015
5	Hepatitis C 12/2014 - 07/2011
4	Liver Diseases (Liver Disease) 01/2021 - 09/2010
4	Hepatitis 01/2021 - 10/2013
3	Hepatic Encephalopathy 11/2020 - 03/2018
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 03/2017
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 05/2017 - 08/2012
2	Non-alcoholic Fatty Liver Disease 08/2020 - 02/2018
2	Disease Progression 07/2019 - 03/2015
2	Inflammation (Inflammations) 07/2019 - 09/2010
2	Ventricular Fibrillation 01/2016 - 04/2013
2	Anemia 07/2011 - 06/2011
2	Thrombosis (Thrombus) 11/2007 - 10/2007
1	Fatty Liver 07/2022
1	Viremia 01/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Autoimmune Pancreatitis 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2020
1	Carcinogenesis 11/2020
1	Portal Hypertension 11/2020
1	Varicose Veins (Varicose Vein) 11/2020

Drug/Important Bio-Agent (IBA)

30	InterferonsIBA 01/2021 - 10/2007
20	Antiviral Agents (Antivirals)IBA 02/2022 - 09/2013
20	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 09/2010
11	daclatasvirIBA 01/2020 - 01/2014
10	asunaprevirIBA 01/2020 - 01/2015
7	AntigensIBA 01/2021 - 01/2009
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 01/2017
6	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2009
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2009
5	CytokinesIBA 05/2022 - 09/2010
5	lenvatinibIBA 01/2022 - 01/2020
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2015
4	SofosbuvirIBA 01/2021 - 11/2017
4	RNA (Ribonucleic Acid)IBA 01/2020 - 07/2012
4	NucleotidesIBA 01/2019 - 10/2013
4	telaprevirIBA 12/2014 - 07/2011
3	Immunoglobulin G (IgG)IBA 01/2022 - 02/2018
3	Circulating Tumor DNAIBA 06/2021 - 09/2015
3	ChemokinesIBA 07/2019 - 01/2011
3	NucleosidesIBA 01/2019 - 01/2018
3	Complementary DNA (cDNA)IBA 05/2017 - 01/2009
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2017 - 08/2012
3	Interferon LambdaIBA 09/2015 - 02/2011
3	MicroRNAs (MicroRNA)IBA 03/2015 - 01/2012
3	Fluorouracil (Carac)FDA LinkGeneric 04/2008 - 10/2007
2	Amino Acids FDA Link 01/2022 - 02/2011
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 05/2016
2	velpatasvirIBA 01/2021 - 11/2020
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 11/2016
2	HLA-DQB1 antigen (HLA DQB1)IBA 12/2020 - 01/2013
2	Fetal Proteins (Fetoprotein)IBA 11/2020 - 01/2018
2	nasIBA 08/2020 - 10/2013
2	EnzymesIBA 01/2020 - 10/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2019 - 07/2012
2	entecavir FDA Link 12/2018 - 01/2018
2	ledipasvirIBA 12/2018 - 11/2017
2	HMGB1 Protein (HMG1)IBA 01/2018 - 01/2018
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 01/2018
2	Alanine Transaminase (SGPT)IBA 01/2018 - 06/2009
2	Hepatitis B e AntigensIBA 01/2018 - 10/2013
2	SimeprevirIBA 03/2017 - 12/2016
2	Protease Inhibitors (Protease Inhibitor)IBA 12/2016 - 11/2014
2	HLA-DP Antigens (HLA-DP)IBA 12/2015 - 10/2011
2	HLA-DQ Antigens (HLA-DQ)IBA 01/2013 - 10/2011
2	Guanosine Triphosphate (GTP)IBA 07/2012 - 09/2010
1	Capsules (Microcapsules)IBA 07/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	myrcludex-BIBA 01/2022
1	N-propionyl-L-valine (A 195)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Biological ProductsIBA 06/2021
1	GlucocorticoidsIBA 01/2021
1	Methylprednisolone FDA LinkGeneric 01/2021
1	hepatitis B surface antigen presurface protein 1IBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Abatacept (Orencia)FDA Link 01/2021
1	Prothrombin (Factor II)IBA 01/2021
1	glecaprevir and pibrentasvirIBA 01/2021
1	Dual Specificity Phosphatase 1IBA 11/2020
1	Activating Transcription Factor 6IBA 11/2020
1	Histone MethyltransferasesIBA 11/2020
1	Apoptosis Regulatory ProteinsIBA 08/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Type 4 Fibroblast Growth Factor ReceptorIBA 01/2020

Therapy/Procedure

46	Therapeutics 01/2022 - 10/2007
6	Liver Transplantation 01/2021 - 11/2011
4	Drug Therapy (Chemotherapy) 01/2018 - 04/2008
2	Hepatectomy 09/2015 - 12/2014
1	Complementary Therapies (Alternative Medicine) 01/2021